Cerca
Close this search box.

Bifidobacterium adolescentis – BA02 (DSM 18351, formerly ALB 1)

Tabella dei contenuti

Clinical indications

constipation, intestinal transit

Area of use

Gastroenterology strain | Constipation – Intestinal transit

Characteristics

DAILY DOSAGE IN CLINICAL STUDY
10 billion CFU


FUNCTIONALITY
Constipation • Intestinal transit

Scientific support

Human clinical trial
Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly (BL03, LP01, BS01, LR05, BA02 and BR03 seperately). CIBUS, 2005; 1(1):23-30.

In vitro studies
a) Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice (LA02, LPC00, LP01, LR04, BR03, BL03 and BA02). J Clin Gastroenterol. Vol 42, Suppl. 3, Part 2, Sept. 2008.
b) Rossi M. et al. fermentation of fructooligosaccharides and inulin by Bifidobacteria: a comparative study of pure and fecal cultures (BA02). Applied and Environmental Microbiology, 2005;71(10):6150-6158.

Oppure effettua il login